AC
CTIC

Avestar Capital’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Avestar Capital’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-600
Closed – – 982
2019
Q2 		$0 Hold
600
– – ﹤0.01% 1028
2019
Q1 		$0 Hold
600
– – ﹤0.01% 1041
2018
Q4 		$0 Hold
600
– – ﹤0.01% 1069
2018
Q3 		$1K Hold
600
– – ﹤0.01% 805
2018
Q2 		$2K Hold
600
– – ﹤0.01% 712
2018
Q1 		$2K Hold
600
– – ﹤0.01% 667
2017
Q4 		$1K Buy
+600
New +$1.76K ﹤0.01% 740

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return